DNA Double-Strand Breaks in Murine Mammary Tumor Cells Induced by Combined Treatment with Doxorubicin and Controlled Stable Cavitation.

Bystander effect Calcium Cavitation DNA double-strand breaks Doxorubicin Potentiation Ultrasound γ-H2AX

Journal

Ultrasound in medicine & biology
ISSN: 1879-291X
Titre abrégé: Ultrasound Med Biol
Pays: England
ID NLM: 0410553

Informations de publication

Date de publication:
10 2021
Historique:
received: 27 11 2020
revised: 28 05 2021
accepted: 31 05 2021
pubmed: 29 7 2021
medline: 28 1 2022
entrez: 28 7 2021
Statut: ppublish

Résumé

Chemotherapeutic agents such as doxorubicin induce cell cytotoxicity through induction of DNA double-strand breaks. Recent studies have reported the occurrence of DNA double-strand breaks in different cell lines exposed to cavitational ultrasound. As ultrasound stable cavitation can potentiate the therapeutic effects of cytotoxic drugs, we hypothesized that combined treatment with unseeded stable cavitation and doxorubicin would lead to increased DNA damage and would reduce cell viability and proliferation in vitro. In this study, we describe how we determined, using 4T1 murine mammary carcinoma as a model cell line, that unseeded stable cavitation combined with doxorubicin leads to additive DNA double-strand break induction. Combined treatment with doxorubicin and unseeded stable cavitation significantly reduced cell viability and proliferation at 72 h. A mechanistic study of the potential mechanisms of action of the combined treatment identified the presence of cavitation necessary to increase early DNA double-strand break induction, likely mediated by a bystander effect with release of extracellular calcium.

Identifiants

pubmed: 34315620
pii: S0301-5629(21)00258-1
doi: 10.1016/j.ultrasmedbio.2021.05.028
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Doxorubicin 80168379AG
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2941-2957

Informations de copyright

Copyright © 2021 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest disclosure The authors declare no competing interests.

Auteurs

Cécile Fant (C)

LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ-Lyon, Lyon, France.

Adeline Granzotto (A)

INSERM, UA8 unit, Centre Léon Bérard, Lyon, France.

Jean-Louis Mestas (JL)

LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ-Lyon, Lyon, France.

Jacqueline Ngo (J)

LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ-Lyon, Lyon, France.

Maxime Lafond (M)

LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ-Lyon, Lyon, France.

Cyril Lafon (C)

LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ-Lyon, Lyon, France.

Nicolas Foray (N)

INSERM, UA8 unit, Centre Léon Bérard, Lyon, France.

Frédéric Padilla (F)

LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ-Lyon, Lyon, France; Focused Ultrasound Foundation, Charlottesville, Virginia, USA; Department of Radiology, University of Virginia School of Medicine, Charlottesville, Virginia, USA. Electronic address: frederic.padilla@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH